01 / DermatologyPhase 3
Vitiligo
87.5%
above the original randomization forecast
WCR randomized 15 participants against an original forecast of 8, exceeding the estimate by 87.5%. The site was sponsor audited with zero findings.
Explore the resultsWellness Clinical Research · Case studies
Results that go
beyond enrollment.
From a faster first screening to participants who stay through completion. Explore the study results behind WCR's approach to preparation, enrollment, and participant engagement.
10 real study stories6 therapeutic areasPhase 1 through Phase 3
Featured case · Phase 2 celiac disease
A demanding protocol.
Complete follow-through.
Diary requirements. A gluten challenge. In-person visits. Our team prepared candidates for the commitment and kept relationships and communication active throughout the trial. All 8 randomized participants completed.
Explore the celiac disease caseEnrollment delivered8 / 6
enrolled / originally forecast
33.3% above forecastComplete follow-through8 / 8
randomized participants completed
100% completionThe evidence, study by study
Find the results
relevant to your protocol.
Ten studies. Six therapeutic areas. Explore startup, enrollment, quality, and completion outcomes, with the protocol challenges, team response, and participant approach behind each story.
10 case studies
02 / CardiovascularPhase 2b
Cardiovascular
43
calendar days from selection to first screening
WCR moved from site selection to first screening in 43 calendar days. All five participants in the initial screening group went on to randomization.
Explore the results03 / DermatologyPhase 1/2
Plaque psoriasis
13
participants randomized from 15 screened
WCR screened 15 participants in less than two months for a Phase 1/2 plaque psoriasis study. Thirteen were randomized, with one screen failure and one early withdrawal.
Explore the results04 / MetabolicPhase 3
Obesity with diabetes
8
participants randomized in a Phase 3 obesity study with diabetes
For a Phase 3 obesity study involving participants with diabetes, WCR screened 15 participants in less than one month and delivered 8 randomizations.
Explore the results05 / MetabolicPhase 3
Obesity
20
randomized from 22 participants screened
WCR screened its first participant two days after activation. The study went on to randomize 20 of 22 screened participants, a 90.9% conversion.
Explore the results06 / VaccinesPhase 1
Influenza immunization
100%
study completion among 47 randomized participants
WCR randomized 47 participants in a Phase 1 influenza immunization study, and all 47 completed the trial within one month. No early withdrawals. No loss to follow-up.
Explore the results07 / DermatologyPhase 3
Moderate-to-severe atopic dermatitis
100%
of enrolled participants completed the trial
WCR reached its enrollment goal in one month for a Phase 3 moderate-to-severe atopic dermatitis study. Thirty percent of randomized participants were ages 12-17, and every enrolled participant completed the trial.
Explore the results08 / GastroenterologyPhase 2
Celiac disease
100%
study completion among all 8 randomized participants
WCR enrolled and randomized 8 participants against an original forecast of 6. All 8 completed the full Phase 2 trial, including diary requirements, a gluten challenge, and in-person visits.
Explore the results09 / GastroenterologyPhase 3
Ulcerative colitis
100%
of randomized participants completed the trial
WCR screened its first participant within three weeks of activation, met its enrollment goal well before study enrollment closed, and achieved 100% participant completion with zero screen failures.
Explore the results10 / NeurologyPhase 3
Pediatric chronic migraine
33.3%
above the original randomization goal
In a demanding Phase 3 pediatric chronic migraine trial, WCR randomized 8 participants against an original goal of 6. Seven completed the trial, with one participant lost to follow-up.
Explore the resultsNo case studies match your selection.
The participant experience
Retention starts before the first screening.
The work behind strong participation begins with clear expectations. Across these studies, WCR paired preparation before screening with participant relationships and open communication throughout the trial. Participants demonstrated high compliance with study requirements.
Set expectations before screening
We discuss the study commitment early, including what participation will require and whether candidates feel ready to meet those expectations. Pre-screening helps establish a shared understanding before the first screening visit.
Build a working relationship
Participants need a team they can talk to. We build relationships throughout the study and keep communication open so questions and practical concerns can be raised with the site.
Keep the focus on follow-through
Our participant engagement approach continues beyond randomization. We stay connected throughout participation to support retention and compliance with study requirements.
Practical participant support
Help with the journey.
Support through the study.
We provide transportation support when needed to help participants attend study visits. We also discuss scheduling concerns early and maintain open communication throughout participation, helping address the practical barriers that can make follow-through difficult.
30%of randomized participants in our atopic dermatitis case were ages 12-17. Explore the study100% participant completion in these individual studies
Your next study
Build your next study
on a stronger start.
Talk with our Miami Lakes and Puerto Rico teams about your protocol, patient population, and the participation demands that matter to your study.